Office of Generic Drugs (OGD)

The Office of Generic Drugs (OGD) is a division of the U.S. Food and Drug Administration (FDA) responsible for overseeing the approval of generic medications. Its mission is to ensure that these alternatives are safe, effective, and of high quality, similar to their brand-name counterparts. Generic drugs are typically less expensive, making them more accessible to patients. The OGD reviews applications from manufacturers to certify that these drugs meet necessary standards before they can be marketed, promoting competition and helping to lower healthcare costs.